Use of selective-serotonin reuptake inhibitors and platelet aggregation inhibitors among individuals with co-occurring atherosclerotic cardiovascular disease and depression or anxiety. [electronic resource]
Publication details: SAGE open medicine 2016Description: 2050312116682255 p. digitalISSN:- 2050-3121
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.